advertisement
11.14 Investigational drugs; pharmacological experiments (7)
Showing records 1 to 7
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments13898 Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes
Ethier CR; Read AT; Chan DW
Investigative Ophthalmology and Visual Science 2006; 47: 1991-1998
13899 Chronic topical administration of WIN-55-212-2 maintains a reduction in IOP in a rat glaucoma model without adverse effects
Hosseini A; Lattanzio FA; Williams PB; Tibbs D; Samudre SS; Allen RC
Experimental Eye Research 2006; 82: 753-759
13900 Effects of antiglaucoma drugs GLC756, a novel dopamine D2 agonist and D1 antagonist, and timolol on endotoxin-induced TNF-α release in serum of rats
Laengle UW; Markstein R; Schneider V; Roman D
European Journal of Ophthalmology 2006; 16: 401-406
13897 Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility
Njie YF; Kumar A; Qiao Z; Zhong L; Song ZH
Investigative Ophthalmology and Visual Science 2006; 47: 1999-2005
13590 The pharmacology of cannabinoid receptors and their ligands: An overview
Pertwee RG
International Journal of Obesity 2006; 30: S13-S18
13626 R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells
Rosch S; Ramer R; Brune K; Hinz B
Journal of Pharmacology and Experimental Therapeutics 2006; 316: 1219-1228
13567 Reduction of the physiologic IOP value after instilation of the mixture of the 2 amino acids (L-lysine and L-arginine) in Timoptol - Experiment on rabbits
Veselovsky J; Olah Z; Vesela A; Gressnerova S
Česka a Slovenska Oftalmologie 2006; 62: 3-10
